Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia.

被引：0

作者：

Lee, JH ^{[1
]}

Choi, SJ ^{[1
]}

Lee, JH ^{[1
]}

Lee, YS ^{[1
]}

Seol, M ^{[1
]}

Ryu, SG ^{[1
]}

Lee, JS ^{[1
]}

Kim, WK ^{[1
]}

Lee, KH ^{[1
]}

机构：

[1] Asan Med Ctr, Seoul, South Korea

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：611S / 611S

页数：1

共 50 条

[31] Etoposide, intermediate-dose cytarabine and carboplatin (VAC): A combination therapy for the blastic phase of chronic myelogenous leukemia [J].

Montefusco, E ;

Petti, MC ;

Alimena, G ;

Latagliata, R ;

Celesti, F ;

Capria, S ;

Amadori, S ;

Avvisati, G ;

Mandelli, F .

ANNALS OF ONCOLOGY, 1997, 8 (02) :175-179

[32] A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia [J].

Christian, Sonia ;

Arain, Saad ;

Patel, Pritesh ;

Khan, Irum ;

Calip, Gregory S. ;

Agrawal, Vaibhav ;

Sweiss, Karen ;

Griffin, Shawn ;

Cahill, Kirk ;

Konig, Heiko ;

Esen, Aysenur ;

Shergill, Ardaman ;

Odenike, Olatoyosi ;

Stock, Wendy ;

Quigley, John G. .

AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (08) :937-943

[33] INDUCTION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS OVER 60 YEARS WITH INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE, MITOXANTRONE AND ETOPOSIDE [J].

SHEPHERD, JD ;

REECE, DE ;

BARNETT, MJ ;

KLINGEMANN, HG ;

NANTEL, SH ;

SUTHERLAND, HJ ;

PHILLIPS, GL .

LEUKEMIA & LYMPHOMA, 1993, 9 (03) :211-215

[34] HIGH-DOSE MERCAPTOPURINE FOLLOWED BY INTERMEDIATE-DOSE CYTARABINE IN RELAPSED ACUTE-LEUKEMIA [J].

LOCKHART, S ;

PLUNKETT, W ;

JEHA, S ;

RAMIREZ, I ;

ZIPF, T ;

CORK, A ;

PINKEL, D .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :587-595

[35] COMBINATION THERAPY WITH MITOXANTRONE AND ETOPOSIDE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA [J].

HO, AD ;

LIPP, T ;

EHNINGER, G ;

MEYER, P ;

FREUND, M ;

HUNSTEIN, W .

CANCER TREATMENT REPORTS, 1986, 70 (08) :1025-1027

[36] Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine [J].

Raanani, P ;

Shpilberg, O ;

Gillis, S ;

Avigdor, A ;

Hardan, I ;

Berkowicz, M ;

Sofer, O ;

Lossos, I ;

Chetrit, A ;

Ben-Yehuda, D ;

Bell-Bassat, I .

LEUKEMIA RESEARCH, 1999, 23 (08) :695-700

[37] SUCCESSFUL TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER RELAPSE WITH PREDNISONE, INTERMEDIATE-DOSE CYTARABINE, MITOXANTRONE, AND ETOPOSIDE (PAME) CHEMOTHERAPY [J].

MILPIED, N ;

GISSELBRECHT, C ;

HAROUSSEAU, JL ;

SEBBAN, C ;

WITZ, F ;

TROUSSARD, X ;

GRATECOS, N ;

MICHALLET, M ;

LEBLOND, V ;

AUZANNEAU, G ;

FIERE, D .

CANCER, 1990, 66 (04) :627-631

[38] MITOXANTRONE AND HIGH-DOSE ETOPOSIDE FOR PATIENTS WITH RELAPSED OR REFRACTORY ACUTE-LEUKEMIA [J].

OBRIEN, S ;

KANTARJIAN, H ;

ESTEY, E ;

KOLLER, C ;

BERAN, M ;

MCCREDIE, K ;

KEATING, M .

CANCER, 1991, 68 (04) :691-694

[39] HIGH-DOSE VERSUS INTERMEDIATE-DOSE CYTARABINE COMBINED WITH MITOXANTRONE FOR THE TREATMENT OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA - RESULTS OF AN AGE-ADJUSTED RANDOMIZED COMPARISON [J].

HIDDEMANN, W ;

AUL, C ;

MASCHMEYER, G ;

SCHONROCKNABULSI, R ;

LUDWIG, WD ;

BARTHOLOMAUS, A ;

BETTELHEIM, P ;

BECKER, K ;

BALLEISEN, L ;

LATHAN, B ;

KOPPLER, H ;

GRUNEISEN, T ;

DONHUIJSENANT, R ;

REICHLE, A ;

BUCHNER, T .

SEMINARS IN HEMATOLOGY, 1991, 28 (03) :35-38

[40] PATIENT-SPECIFIC DOSE-RATE FOR CONTINUOUS INFUSION HIGH-DOSE CYTARABINE IN RELAPSED ACUTE MYELOGENOUS LEUKEMIA [J].

HEINEMANN, V ;

ESTEY, E ;

KEATING, MJ ;

PLUNKETT, W .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (05) :622-628

← 1 2 3 4 5 →